Leerink Swann Upgrades Shire plc (SHPGY) to Outperform; Market Opportunity Looks Compelling

Article Stock Quotes (1) Comments (0)

Leerink Swann upgraded Shire plc (NASDAQ: SHPGY) from Market Perform to Outperform with a price target of $110.00 (from $106.00).

Analyst, Jason M. Gerberry, said, "We are upgrading SHPGY for several reasons (1) the underappreciated potential of Vyvanse in adjunctive Major Depressive Disorder (aMDD) based on increasingly positive feedback from MEDACorp clinical KOL’s, our discussions with SHPGY and the fact that we could see topline Ph. III data in the next 12-18 months; (2) a valuation that we believe largely reflects the generic risks to Adderall XR and Intuniv; and (3) cont’d strong US ADHD Rx trends."

FY12 EPS estimate raised from $6.08 to $6.09 and FY13 from $7.14 to $6.79.

For an analyst ratings summary and ratings history on Shire plc click here. For more ratings news on Shire plc click here.

Shares of Shire plc closed at $87.37 yesterday, with a 52 week range of $82.11-$108.79.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• UPDATE: BofA/Merrill Lynch Upgrades Adobe (ADBE) to Buy
• UPDATE: Bernstein Cuts BlackBerry (BBRY) to Underperform; Notes Weak BB10 Traction
• Goldman Sachs Upgrades Tanger Factory Outlet Centers (SKT) to Neutral

Create E-mail Alert Related Categories

Analyst EPS Change, Analyst EPS View, Analyst PT Change, Upgrades

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?